Analysis of the Circulating Metabolome of Patients with Cutaneous, Mucosal and Uveal Melanoma Reveals Distinct Metabolic Profiles with Implications for Response to Immunotherapy

SIMPLE SUMMARY: Advanced melanoma is an aggressive cancer with a historical 12-month median survival after the diagnosis. This scenario has greatly changed since the advent of immunotherapy. Unfortunately, half of patients do not respond to this treatment and rare types of melanomas such as mucosal...

Descripción completa

Detalles Bibliográficos
Autores principales: Vilbert, Maysa, Koch, Erica C., Rose, April A. N., Laister, Rob C., Gray, Diana, Sotov, Valentin, Penny, Susanne, Spreafico, Anna, Pinto, Devanand M., Butler, Marcus O., Saibil, Samuel D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378038/
https://www.ncbi.nlm.nih.gov/pubmed/37509369
http://dx.doi.org/10.3390/cancers15143708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378038/
https://www.ncbi.nlm.nih.gov/pubmed/37509369
http://dx.doi.org/10.3390/cancers15143708

Ejemplares similares